Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 100.
392. lappuse
... flask . For the 200 - milligram tablets , pipet 10.0 milli- liters of the filtered sample into a 50- milliliter volumetric flask . Dilute to volume with 0.05 M postassium phos- phate buffer , pH 7.2 . ( iii ) Procedure . Proceed as ...
... flask . For the 200 - milligram tablets , pipet 10.0 milli- liters of the filtered sample into a 50- milliliter volumetric flask . Dilute to volume with 0.05 M postassium phos- phate buffer , pH 7.2 . ( iii ) Procedure . Proceed as ...
393. lappuse
... flask . Add 25 milliliters of the dissolution medium and sonicate brief- ly . Dilute to volume with dissolution medium and mix well . Pipet 2.0 milli- liters of this solution into a 25 - milli- liter volumetric flask and dilute to vol ...
... flask . Add 25 milliliters of the dissolution medium and sonicate brief- ly . Dilute to volume with dissolution medium and mix well . Pipet 2.0 milli- liters of this solution into a 25 - milli- liter volumetric flask and dilute to vol ...
402. lappuse
... flask , add sufficient pyri- dine to dissolve , and make to mark . Transfer a 1 - milliliter aliquot to a glass ... flask . Agitate the flasks to insure dissolution of the sample and working standard and complete mixing of the liquids ...
... flask , add sufficient pyri- dine to dissolve , and make to mark . Transfer a 1 - milliliter aliquot to a glass ... flask . Agitate the flasks to insure dissolution of the sample and working standard and complete mixing of the liquids ...
408. lappuse
... flask . Dissolve and dilute to volume with 0.01N HCl . Transfer a 2.0 - milliliter aliquot of this solution to a 200 - milli- liter volumetric flask and dilute to vol- ume with 0.001N HCl . ( c ) Procedure . Using 0.001N HCl as the ...
... flask . Dissolve and dilute to volume with 0.01N HCl . Transfer a 2.0 - milliliter aliquot of this solution to a 200 - milli- liter volumetric flask and dilute to vol- ume with 0.001N HCl . ( c ) Procedure . Using 0.001N HCl as the ...
410. lappuse
... flask . Dissolve and dilute to volume with methyl alco- hol . Transfer 2.0 milliliters of this solu- tion to a 200 - milliliter volumetric flask and dilute to volume with distilled water . This is the standard solution . Transfer a 2.0 ...
... flask . Dissolve and dilute to volume with methyl alco- hol . Transfer 2.0 milliliters of this solu- tion to a 200 - milliliter volumetric flask and dilute to volume with distilled water . This is the standard solution . Transfer a 2.0 ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning